BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19298852)

  • 1. Gamma-glutamyltransferase-dependent resistance to arsenic trioxide in melanoma cells and cellular sensitization by ascorbic acid.
    Giommarelli C; Corti A; Supino R; Favini E; Paolicchi A; Pompella A; Zunino F
    Free Radic Biol Med; 2009 Jun; 46(11):1516-26. PubMed ID: 19298852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular response to oxidative stress and ascorbic acid in melanoma cells overexpressing gamma-glutamyltransferase.
    Giommarelli C; Corti A; Supino R; Favini E; Paolicchi A; Pompella A; Zunino F
    Eur J Cancer; 2008 Mar; 44(5):750-9. PubMed ID: 18314325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative investigations of sodium arsenite, arsenic trioxide and cadmium sulphate in combination with gamma-radiation on apoptosis, micronuclei induction and DNA damage in a human lymphoblastoid cell line.
    Hornhardt S; Gomolka M; Walsh L; Jung T
    Mutat Res; 2006 Aug; 600(1-2):165-76. PubMed ID: 16764896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells.
    Corti A; Duarte TL; Giommarelli C; De Tata V; Paolicchi A; Jones GD; Pompella A
    Mutat Res; 2009 Oct; 669(1-2):112-21. PubMed ID: 19505483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells.
    Corti A; Raggi C; Franzini M; Paolicchi A; Pompella A; Casini AF
    Free Radic Biol Med; 2004 Dec; 37(11):1906-15. PubMed ID: 15528049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis signal-regulating kinase 1 is crucial for oxidative stress-induced but not for osmotic stress-induced hepatocyte cell death.
    Taki K; Shimozono R; Kusano H; Suzuki N; Shinjo K; Eda H
    Life Sci; 2008 Dec; 83(25-26):859-64. PubMed ID: 18983857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic metabolism in multiple myeloma and astrocytoma cells.
    Falnoga I; Slejkovec Z; Pucer A; Podgornik H; Tusek-Znidaric M
    Biol Trace Elem Res; 2007 Apr; 116(1):5-28. PubMed ID: 17634624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway.
    Ghosh J; Das J; Manna P; Sil PC
    Toxicol Appl Pharmacol; 2009 Oct; 240(1):73-87. PubMed ID: 19616567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic, genotoxic and oxidative stress induced by 1,4-naphthoquinone in B16F1 melanoma tumor cells.
    Kumar MR; Aithal K; Rao BN; Udupa N; Rao BS
    Toxicol In Vitro; 2009 Mar; 23(2):242-50. PubMed ID: 19121382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells.
    Zhang H; Duncan G; Wang L; Liu P; Cui H; Reddan JR; Yang BF; Wormstone IM
    Exp Eye Res; 2007 Dec; 85(6):825-35. PubMed ID: 17963750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
    Sánchez Y; Calle C; de Blas E; Aller P
    Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells.
    Franzini M; Corti A; Lorenzini E; Paolicchi A; Pompella A; De Cesare M; Perego P; Gatti L; Leone R; Apostoli P; Zunino F
    Eur J Cancer; 2006 Oct; 42(15):2623-30. PubMed ID: 16928443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor cell apoptosis or necrosis by conditional expression of cell death proteins: analysis of cell death pathways and in vitro immune stimulatory potential.
    Lohmann C; Muschaweckh A; Kirschnek S; Jennen L; Wagner H; Häcker G
    J Immunol; 2009 Apr; 182(8):4538-46. PubMed ID: 19342627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intracellular ascorbate on the susceptibility of HL60 and Jurkat cells to chemotherapy agents.
    Gokhalé P; Patel T; Morrison MJ; Vissers MC
    Apoptosis; 2006 Oct; 11(10):1737-46. PubMed ID: 16951922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased aquaglyceroporin 9 expression disrupts arsenic resistance in human lung cancer cells.
    Miao ZF; Chang EE; Tsai FY; Yeh SC; Wu CF; Wu KY; Wang CJ; Tsou TC
    Toxicol In Vitro; 2009 Mar; 23(2):209-16. PubMed ID: 19100828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma.
    Wu KL; Beksac M; van Droogenbroeck J; Amadori S; Zweegman S; Sonneveld P
    Haematologica; 2006 Dec; 91(12):1722-3. PubMed ID: 17145617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.